Dose response of ACE inhibitors: implications of the SECURE trial
The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well as in chronic coronary artery disease, high doses of angiotensin-converting enzyme (ACE) inhibitor are more effective than low ones. T...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59639/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806789/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-4-155 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|